This website uses cookies so that we can offer you the best possible user experience. The cookie information is stored in your browser and performs functions such as recognizing you when you return to our website or helping our team to understand which sections of the website you find most interesting and useful.
By: Fundación Kærtor
Diario Medico report of a summer course about Personalized Medicine and innovation funding in healthcare
3 October, 2018Ángel Carracedo explained the bet of Galicia for the Public Procurement of Innovation, to which 90 million € has been addressed since 2012.
Read More
Recent interview to Mabel Loza, Scientific Director, in La Voz De Galicia S.A. about Kærtor and I2D2 selected projects
20 August, 2018La Voz de Galicia has interviewed Mabel Loza to learn about the work being done by the Kaertor Foundation and Janssen Pharmaceutical.
Read More
Smart financing and public-private collaboration mark the future of biomedicine.
19 June, 2018Kærtor Foundation and I2D2 representatives were present past week in the FARMAINDUSTRIA meeting to discuss the future of biomedicine.
Read More
Article in El Correo Gallego: “Angel Carracedo and Mabel Loza, included in the 2018 ranking of the “125 most influential personalities in Galicia”
18 June, 2018The Scientific Directors of the Kaertor Foundation, included in the 2018 ranking of the “125 most influential personalities in Galicia”. Angel Carracedo is ranked 8th as the first scientist on the list, while Mabel Loza is ranked 33rd as the first scientific woman in this ranking.
Read More
How to measure applied research
15 June, 2018The Kærtor Foundation is organising a workshop aimed at establishing new open innovation indicators which will allow the transfer of research results to be measured objectively.
Read More
The Kærtor Foundation will attend the 2018 OurCrowd Global Investor Summit in Israel along with other Galician entrepreneurial and project incubation initiatives
8 February, 2018The Kærtor Foundation, along with various other Galician initiatives, attended the 2018 OurCrowd Global Investor Summit in Israel where they presented their work in sectors which feature Israeli companies as world leaders.
Read More
More than 150 Expressions of Interest from all over the world respond to the call made by the I2D2 initiative, the Galician incubator for new drugs, and the first of its kind in Spain
5 December, 2017Arising from the alliance of the Xunta de Galicia, through the Ministry of Economy, Employment and Industry, the Kærtor Foundation and the Janssen company, the initiative has secured investment of more than 2 million euros.
Read MoreEvaluation, selection and scientific leadership of drug discovery programs within the 12D2 initiative.
6 September, 2017The Kærtor Foundation offers employment opportunities within the I2D2 program “to create an incubator for drug discovery projects”. The position will…
Read More
Francis Mojica receives the Albany Prize, the most prestigious Medicine award in the USA
15 August, 2017Francis Mojica, a scientist from the University of Alicante, is one of five people selected to receive the Albany Medical Center Prize in Medicine and Biomedical Research for 2017, the most prestigious award in the United States and one of the most important awards in the world in Medicine and biomedical research.
Read More
The Kærtor Foundation with the Xunta de Galicia and Janssen sets up the first drug design and discovery incubator in Spain
20 July, 2017The organisation, the Ministry of Economy, Employment and Industry, through the Galician Innovation Agency, and the Janssen pharmaceutical company, will invest more than 2 million euros.
Read More